When was Cellular Origins founded?

Cellular Origins was founded in 2022 and raised its 1st funding round 3 years after it was founded.

Where is Cellular Origins located?

Cellular Origins is headquartered in Melbourn, United Kingdom.

Who is the current CEO of Cellular Origins?

Edwin Stone of Cellular Origins. They have also founded 1 company.

How many employees does Cellular Origins have?

As of Jun 30, 2026, the latest employee count at Cellular Origins is 105.

Is Cellular Origins a funded company?

Cellular Origins is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Dec 09, 2025.

When was the latest funding round of Cellular Origins?

Cellular Origins' latest funding was a $***** Series A round on Dec 09, 2025, with participation from 5 investors.

Where does Cellular Origins rank among its competitors?

Cellular Origins ranks 4th amongst 26 active competitors, of which 10 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Cellares, which secured $20M in Jun, 2026.

Who are the top competitors of Cellular Origins?

Cellular Origins' top competitors include Oribiotech, Cellares and Multiply Labs. Among them, Cellares secured the most recent funding round in June, 2026.

Cellular Origins - 2026 Company Profile, Team, Funding & Competitors

Cellular Origins is a series A company based in Melbourn (United Kingdom), founded in 2022 by Edwin Stone. It operates as a Provider of automated manufacturing solution for cell and gene therapy. Cellular Origins has raised $40M in funding from Johnson & Johnson. The company has 26 active competitors, including 10 funded and 1 that has exited. Its top competitors include companies like Oribiotech, Cellares and Multiply Labs.

Company Details

Provider of automated manufacturing solution for cell and gene therapy. It offers Constellation a closed, configurable, robotic platform for the production of cell and gene therapy. It deliver GMP-compliant, full cell therapy automation for scaling cell therapy manufacturing.

Website: cellularorigins.com
Social
Email ID: *****@cellularorigins.com
Phone Number: +44 **********
Part Of

Key Metrics

Founded Year

2022

Location

Melbourn, United Kingdom

Stage

Series A

Total Funding

$40M in 1 round

Latest Funding Round

Series A, Dec 09, 2025, $*****

Investors

Johnson & Johnson & 4 more

Ranked

4^th among 26 active competitors

Employee Count

105 as on Jun 30, 2026

Similar Companies

Oribiotech & 25 more

View Cellular Origins' full profile

Cellular Origins has raised a total funding of $40M over 1 round. Its latest funding round was a Series A round on Dec 09, 2025 for $*****. 5 investors participated in its latest round. Cellular Origins has 5 institutional investors.

Here is the list of recent funding rounds of Cellular Origins:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 09, 2025	6681014	Series A	5724991	3938587	6298627	7508815

Access funding benchmarks and valuations. Sign up today!

View details of Cellular Origins's funding rounds and investors

The founders of Cellular Origins is Edwin Stone. Edwin Stone is the CEO of Cellular Origins.

Here are the details of Cellular Origins' key team members:

Edwin Stone: Founder & CEO of Cellular Origins.
Contact Info: 1 email address

View details of Cellular Origins's Founder profiles and Board Members

Cellular Origins' employee count trend

Cellular Origins has 105 employees as of Jun 26. Here is Cellular Origins's employee count trend over the years:

Employee count trend for Cellular Origins

Uncover Cellular Origins' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cellular Origins include Oribiotech, Cellares and Multiply Labs. Here is the list of Top 10 competitors of Cellular Origins, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Oribiotech 2015, London (United Kingdom), Series B	Biotech company focused on advancing cell and gene therapy manufacturing through innovative automation tool	$281M	Novalis LifeSciences, Octopus Ventures & 17 others	66/100
2nd	Cellares 2019, San Francisco (United States), Series D	Manufacturer of a medical device for cell-based therapy	$632M	Eclipse, BlackRock & 17 others	64/100
3rd	Multiply Labs 2016, San Francisco (United States), Series A	Manufacturer of precision medicines through innovative robotic technology	$41.3M	Zillionize, Casdin Capital & 22 others	64/100
4th	Cellular Origins 2022, Melbourn (United Kingdom), Series A	Provider of automated manufacturing solution for cell and gene therapy	$40M	Highland Europe, BGF & 3 others	55/100
5th	Astraveus 2016, Paris (France), Seed	Provider of a device for autologous cell and gene therapies	$18M	AdBio partners, Bpifrance & 5 others	55/100
6th	Celltrio 2018, Fremont (United States), Series B	Developer of automated biobanking and cell culture systems	$15M	Premier Partners	48/100
7th	Unicorn Biotechnologies 2020, Sheffield (United Kingdom), Seed	Developer of bioreactors for cell-based manufacturing	$3.2M	Acequia Capital, HAX & 9 others	43/100
8th	Shenzhen Shenyan Biotechnology 2014, Shenzhen (China), Series B	Developer of automated cell processing system	$56.7M	Eight Roads Ventures, Tasly & 3 others	40/100
9th	ThermoGenesis 1986, Rancho Cordova (United States), Public	Provider of automated technologies for cell-based therapeutics and bio-processing	-	Bay City Capital, HHS	40/100
10th	Cell X Technologies 2017, Cleveland (United States), Funding Raised	Developer of regenerative medicine to measure and manage human cell sources	-	Denniston Family Office, Innovation Works ... & 2 others	35/100